FDA Approves First Blood Test to Detect Specific Mutations in Non-Small Cell Lung Cancer
Lung Cancer, News
The U.S Food and Drug Administration (FDA) has approved the first blood-based genetic test designed to detect mutations in the epidermal growth factor receptor (EGFR) gene in non-small cell lung cancer (NSCLC) ... Read more